tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)

C71H72LaN13O6 — CID 139128391

IUPACtetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)
SMILESCC#N.CC#N.CC#N.CC#N.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.[La+3]
InChIInChI=1S/3C21H21N3O2.4C2H3N.La/c3*1-3-4-12-24-18-11-9-15(26-2)13-17(18)23-21(24)16-10-8-14-6-5-7-19(25)20(14)22-16;4*1-2-3;/h3*5-11,13,25H,3-4,12H2,1-2H3;4*1H3;/q;;;;;;;+3/p-3
InChIKeyJPAZTJMICYRVOR-UHFFFAOYSA-K
MW1342.35 g/mol
LogP14.52
Rot. Bonds15

About tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)

tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+) (PubChem CID 139128391) has the molecular formula C71H72LaN13O6 and a molecular weight of 1342.35 g/mol. Its IUPAC name is tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+).

Molecular Properties

Compound Nametetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)
PubChem CID139128391
Molecular FormulaC71H72LaN13O6
Molecular Weight1342.35 g/mol
Exact Mass1341.48
IUPAC Nametetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)
SMILESCC#N.CC#N.CC#N.CC#N.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.[La+3]
InChIInChI=1S/3C21H21N3O2.4C2H3N.La/c3*1-3-4-12-24-18-11-9-15(26-2)13-17(18)23-21(24)16-10-8-14-6-5-7-19(25)20(14)22-16;4*1-2-3;/h3*5-11,13,25H,3-4,12H2,1-2H3;4*1H3;/q;;;;;;;+3/p-3
InChIKeyJPAZTJMICYRVOR-UHFFFAOYSA-K
XLogP14.52
TPSA284.16 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds15
Heavy Atoms91
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001342.35
LogP ≤ 514.52
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Analyze tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)?
The IUPAC name of tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+) (CID 139128391) is tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+).
What is the SMILES notation for tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)?
The canonical SMILES for tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+) is CC#N.CC#N.CC#N.CC#N.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.CCCCn1c(-c2ccc3cccc([O-])c3n2)nc2cc(OC)ccc21.[La+3].
What is the InChIKey of tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)?
The InChIKey is JPAZTJMICYRVOR-UHFFFAOYSA-K. The full InChI is InChI=1S/3C21H21N3O2.4C2H3N.La/c3*1-3-4-12-24-18-11-9-15(26-2)13-17(18)23-21(24)16-10-8-14-6-5-7-19(25)20(14)22-16;4*1-2-3;/h3*5-11,13,25H,3-4,12H2,1-2H3;4*1H3;/q;;;;;;;+3/p-3.
What are the key properties of tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+)?
tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+) has a molecular weight of 1342.35 g/mol, XLogP of 14.52, 15 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(acetonitrile);tris(2-(1-butyl-5-methoxybenzimidazol-2-yl)quinolin-8-olate);lanthanum(3+) is sourced from PubChem (CID 139128391), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).